Edition:
United States

Rocky Swift

Japan's Shionogi readies COVID-19 vaccine for December trial: CEO

Oct 28 2020

TOKYO Shionogi & Co is planning clinical trials by year-end for what may be one of Japan's first domestically produced COVID-19 vaccines to reach the market, as the globe races to secure enough doses to battle the pandemic.

Japan PM's meddling in science panel a 'dangerous direction': scholars

Oct 23 2020

TOKYO Scholars excluded from Japan's top science advisory panel said the move was unconstitutional and a dangerous sign of how newly installed Prime Minister Yoshihide Suga will wield power.

Japan researchers show masks do block coronavirus, but not perfectly

Oct 22 2020

TOKYO Japanese researchers showed that masks can offer protection from airborne coronavirus particles, but even professional-grade coverings can't eliminate contagion risk entirely.

Japan supercomputer shows humidity affects aerosol spread of coronavirus

Oct 14 2020

TOKYO A Japanese supercomputer showed that humidity can have a large effect on the dispersion of virus particles, pointing to heightened coronavirus contagion risks in dry, indoor conditions during the winter months. | Video

Japan supercomputer shows humidity affects aerosol spread of coronavirus

Oct 14 2020

TOKYO, Oct 14 A Japanese supercomputer showed that humidity can have a large effect on the dispersion of virus particles, pointing to heightened coronavirus contagion risks in dry, indoor conditions during the winter months.

Japan health workers snub COVID-19 database as PM Suga seeks to digitize government

Sep 30 2020

TOKYO Japanese health workers are snubbing the government's real-time COVID-19 database introduced in the middle of the pandemic to better deal with outbreaks, pointing to hurdles for the new prime minister's goal of digitising the government.

Japanese researchers trial early warning test for acute COVID-19 cases

Sep 25 2020

TOKYO Japanese researchers have developed a blood test they say appears to serve as an early warning system for serious cases of COVID-19, and deployed 500 prototype machines to trial its effectiveness nationwide.

Takeda-led COVID-19 plasma product to begin trial this month

Sep 17 2020

TOKYO An experimental COVID-19 therapy using blood plasma, developed by Japan's Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays.

World News